Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. (Q54430804)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1986

edit

Language	Label	Description	Also known as
English	Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.	scientific article published in April 1986

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

title

Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

main subject

gentamicin

0 references

author name string

S Mehtar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

Y Drabu

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

P Blakemore

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

publication date

1 April 1986

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

published in

European journal of clinical microbiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

page(s)

248-251

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

cites work

Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2941293

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2941293

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational resistance to 4-quinolone antibacterial agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2941293

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF02014001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

PubMed publication ID

2941293

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2941293

retrieved

29 May 2018

reference URL

http://europepmc.org/abstract/MED/2941293

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54430804&oldid=1381260557"